NWBO · Northwest Biotherapeutics Inc · Share Buybacks
$0.17
0.00 (-0.99%)
At close · Aug 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because of recurring operating losses and operating cash flow deficits, there is substantial doubt about the Company’s ability to continue as a going concern for at least one year from the date of this filing. The consolidated financial statements have been prepared assuming that the Company will continue as a going concern, however, they do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets, or the amounts and classification of liabilities that may result from the outcome of this uncertainty.”View the 10-Q filed Aug 14, 2026
Market Cap
$289.96M
Shares
1.71B
Volume · Aug 21
3.19M
Avg daily vol (3M)
2.98M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2015-12-31 | $0 | 10-K, filed 2016-03-16 |
| 2014-12-31 | $0 | 10-K, filed 2016-03-16 |
| 2013-12-31 | $240,000 | 10-K, filed 2016-03-16 |